EMEA Issues Negative Opinion For Novartis’ Anti-Infective Mycograb
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm also receives positive opinions from EU authorities on hypertension combo Exforge and macular degeneration treatment Lucentis.